In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Twelve hospitals across India will be part of the network which will support the trial in India
Ties up with Denmark’s Vestfrost Solutions, to cater to the unique needs of the Indian market
Construction is now underway with the facility scheduled to be operational by 2025
MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Subscribe To Our Newsletter & Stay Updated
